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Actin related protein (Arp2/3) complex plays important roles in
movement, endocytosis, and cell division. Constructing and
deconstructing of actin mediates cellular motility.1 The Arp2/3 protein
contributes to movement by creating branches. Arp2/3 can get
disturbed by viral and bacterial pathogens, and metastasis of cancer
cells is linked to Arp 2/3 activity.2 As a result, potent inhibitors that can
block or prevent Arp2/3 to nucleate daughter strands of actin will be
helpful as a basic research tool. Also they potentially can be used
against cancers or diseases that use Arp 2/3 to survive.
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The known small molecule inhibitor (CK-666) has been identified
through high throughput screening,5 and characterized by X-ray
crystallography.6 It is highly desirable to develop more potent
derivatives of this inhibitor class. Ideally our goal is to increase the
potency towards Arp2/3 complex by three orders of magnitude.
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Arp2/3 attaches to the side of a preexisting filament of
actin and templates formation of a daughter branch
that grows out at a precise 70° angle
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The Grandberg Synthesis10 can
produce 2-methyltryptamine in
one step and will allow us to
avoid the low-yielding reduction
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materials can be accessed 
through our initial 3-step route11
We study the potency of our inhibitor candidates by              Gemini XPS Microplate Reader
measuring the rate of polymerization of actin in the 
presence of Arp2/3 complex and inhibitors12
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